News

Remote electrical neuromodulation device helps reduce migraine days
- Author:
- Jeff Craven
The device decreased the number of migraine days by an average of 4 days per month.
News
Brepocitinib improves symptoms of mild to moderate AD in phase 2b trial
- Author:
- Jeff Craven
In addition to AD, brepocitinib is currently being developed as a treatment for dermatomyositis, systemic lupus erythematosus, hidradenitis...
News
ICD-10 code can identify patients with melasma for future study
- Author:
- Jeff Craven
“Overall, our results support the validity of using the ICD-10 code for melasma to identify patients with a diagnosis of melasma for future...
News
Immediate skin-to-skin contact after cesarean section improves outcomes for parent, newborn
- Author:
- Jeff Craven
“One of the greatest take-home points from the study was that early skin-to-skin really promoted initiation of breastfeeding.”
News

Health care providers should have higher suspicion for rare diseases
- Author:
- Jeff Craven
Learning to recognize when a cluster of symptoms doesn’t fit a pattern is important, as patients and their providers tend to gravitate toward...
News

Headache for inpatients with COVID-19 may predict better survival
- Author:
- Jeff Craven
Headache arising secondary to COVID-19 infection may be a marker of enhanced likelihood of survival.
News
Body-brain neuroinflammation loop may cause chronic ME/CFS, long COVID symptoms
- Author:
- Jeff Craven
ME/CSF and long COVID are biologically based and involve ‘much disturbed physiology.’
News

Large study reaffirms rare risk of TNF inhibitor–induced psoriasis in patients with RA, IBD
- Author:
- Jeff Craven
Compared with conventional treatment, the risk of developing nonpustular psoriasis was twofold higher among patients receiving TNFi treatment.
News
Therapeutic patient education can help with adherence to treatment
- Author:
- Jeff Craven
Therapeutic patient education is recommended for children and adults with moderate to severe AD in the 2020 European Task Force on Atopic...
News
Steroid phobia drives weaker prescribing, nonadherence for AD
- Author:
- Jeff Craven
The source of these fears can be information from friends, relatives, media, the Internet, as well as doctors.
News

Repurposed drug could revolutionize stem cell transplantation
- Author:
- Jeff Craven
Abatacept to prevent for acute graft-versus-host disease is a game changer for patients receiving hematopoietic stem cell transplants who lack...
News
Early treatment may delay atherosclerosis in familial hypercholesterolemia
- Author:
- Jeff Craven
Cholesterol-lowering treatment early in life appeared to slow intima-media growth in a meta-analysis.
News

Health disparities exist all over rheumatology: What can be done?
- Author:
- Jeff Craven
Health equity should be a “desirable goal” for patients who experience health disparities, but it needs to be a “continuous effort,” said Dr....
News

Rheumatology patients seek guidance on CBD, cannabis products
- Author:
- Jeff Craven
Dr. Orrin Troum suggests putting away any personal biases you may have to learn how to best advise patients who are using or considering using...
News

Treat-to-target in RA: Questions remain about adoption, measurement
- Author:
- Jeff Craven
Rheumatologists Jack Cush and Martin Bergman debate the value of using a treat-to-target approach in managing patients with RA, focusing on...